Status: Not yet recruiting
Clinical Use Study of SAPH Device for Patent Hemostasis After a Transradial Procedure
This is a prospective, multicenter study intended to provide supportive clinical information on the use of the SAPH device to achieve radial artery patent hemostasis after a transradial procedure.
Participants needed: 50
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Transradial Technologies, LLCUpdated: Jul 15, 2025
Eligibility criteria
Patient is 21 years or older. [+4]
Patient had a prior ipsilateral TRA procedure [+10]